Tantia Constructions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:02 pm

Quick Insight

Tantia Constructions Ltd, with a share price of ₹30.0 and a market cap of ₹465 Cr., presents an intriguing investment opportunity in the construction and contracting sector, boasting a low P/E ratio of 4.74 and impressive return metrics with ROE at 35.6% and ROCE at 17.2%. The company's robust operational performance is evident with an OPM of 46% and a healthy net profit of ₹56 Cr. However, the high CCC of 470 days and significant borrowings of ₹339 Cr raise concerns about liquidity and leverage. With a strong promoter holding of 87.69% and a diverse shareholder base, Tantia Constructions' current P/BV of 1.59x and ICR of 50.78x indicate solid financial health and potential for growth, making it a stock to watch closely for future developments.

Competitors of Tantia Constructions Ltd

All Competitor Stocks of Tantia Constructions Ltd

Quarterly Result

Last Updated: August 4, 2025, 10:35 am

Below is a detailed analysis of the quarterly data for Tantia Constructions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Dec 2024) to 50.00 Cr., marking an increase of 35.00 Cr..
• For Expenses, as of Mar 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 15.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Dec 2024) to 23.00 Cr., marking an increase of 20.00 Cr..
• For OPM %, as of Mar 2025, the value is 46.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Dec 2024) to 46.00%, marking an increase of 26.00%.
• For Other Income, as of Mar 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 34.00 Cr., marking an increase of 34.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 56.00 Cr., marking an increase of 54.00 Cr..
• For Tax %, as of Mar 2025, the value is 5.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2024) to 5.00%, marking an increase of 5.00%.
• For Net Profit, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 53.00 Cr., marking an increase of 51.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.41. The value appears strong and on an upward trend. It has increased from 0.11 (Dec 2024) to 3.41, marking an increase of 3.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 4, 2025, 10:35 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 4, 2025, 10:35 am

Below is a detailed analysis of the balance sheet data for Tantia Constructions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
• For Reserves, as of Mar 2025, the value is 288.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2024) to 288.00 Cr., marking an increase of 56.00 Cr..
• For Borrowings, as of Mar 2025, the value is 339.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 334.00 Cr. (Mar 2024) to 339.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 12.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 724.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 650.00 Cr. (Mar 2024) to 724.00 Cr., marking an increase of 74.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 422.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 422.00 Cr..
• For Investments, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 289.00 Cr.. The value appears strong and on an upward trend. It has increased from 214.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 75.00 Cr..
• For Total Assets, as of Mar 2025, the value is 724.00 Cr.. The value appears strong and on an upward trend. It has increased from 650.00 Cr. (Mar 2024) to 724.00 Cr., marking an increase of 74.00 Cr..

However, the Borrowings (339.00 Cr.) are higher than the Reserves (288.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Tantia Constructions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 5. It has decreased from 10.79 (Mar 24) to 3.62, marking a decrease of 7.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 5. It has decreased from 10.79 (Mar 24) to 3.62, marking a decrease of 7.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.73. This value is within the healthy range. It has increased from -1.28 (Mar 24) to 3.73, marking an increase of 5.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 19.59. It has increased from 15.97 (Mar 24) to 19.59, marking an increase of 3.62.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 19.59. It has increased from 15.97 (Mar 24) to 19.59, marking an increase of 3.62.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5.47. It has increased from 3.42 (Mar 24) to 5.47, marking an increase of 2.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.91. This value is within the healthy range. It has increased from -0.29 (Mar 24) to 6.91, marking an increase of 7.20.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.79. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 6.79, marking an increase of 7.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.80. This value is within the healthy range. It has increased from -1.17 (Mar 24) to 3.80, marking an increase of 4.97.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has increased from -1.43 (Mar 24) to 3.61, marking an increase of 5.04.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has increased from -1.43 (Mar 24) to 3.61, marking an increase of 5.04.
• For PBDIT Margin (%), as of Mar 25, the value is 126.26. This value is within the healthy range. It has increased from -8.74 (Mar 24) to 126.26, marking an increase of 135.00.
• For PBIT Margin (%), as of Mar 25, the value is 124.11. This value exceeds the healthy maximum of 20. It has increased from -13.21 (Mar 24) to 124.11, marking an increase of 137.32.
• For PBT Margin (%), as of Mar 25, the value is 69.38. This value is within the healthy range. It has increased from -34.23 (Mar 24) to 69.38, marking an increase of 103.61.
• For Net Profit Margin (%), as of Mar 25, the value is 65.96. This value exceeds the healthy maximum of 10. It has increased from -41.88 (Mar 24) to 65.96, marking an increase of 107.84.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 65.96. This value exceeds the healthy maximum of 20. It has increased from -41.88 (Mar 24) to 65.96, marking an increase of 107.84.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.43. This value is within the healthy range. It has increased from -8.97 (Mar 24) to 18.43, marking an increase of 27.40.
• For Return on Capital Employeed (%), as of Mar 25, the value is 30.35. This value is within the healthy range. It has increased from -2.38 (Mar 24) to 30.35, marking an increase of 32.73.
• For Return On Assets (%), as of Mar 25, the value is 7.73. This value is within the healthy range. It has increased from -3.41 (Mar 24) to 7.73, marking an increase of 11.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.15 (Mar 24) to 0.11, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.12. This value exceeds the healthy maximum of 1. It has decreased from 1.35 (Mar 24) to 1.12, marking a decrease of 0.23.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.12. It has increased from 0.07 (Mar 24) to 0.12, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1.5. It has increased from 0.36 (Mar 24) to 0.50, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 24) to 0.44, marking an increase of 0.17.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 4. It has decreased from 0.41 (Mar 24) to 0.36, marking a decrease of 0.05.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 50.78. This value is within the healthy range. It has increased from -3.14 (Mar 24) to 50.78, marking an increase of 53.92.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 48.54. This value is within the healthy range. It has increased from -7.48 (Mar 24) to 48.54, marking an increase of 56.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 814.80. It has decreased from 856.55 (Mar 24) to 814.80, marking a decrease of 41.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.60. This value exceeds the healthy maximum of 3. It has decreased from 16.15 (Mar 24) to 9.60, marking a decrease of 6.55.
• For EV / EBITDA (X), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from -184.60 (Mar 24) to 7.60, marking an increase of 192.20.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.70. This value exceeds the healthy maximum of 3. It has decreased from 10.01 (Mar 24) to 5.70, marking a decrease of 4.31.
• For Price / BV (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 1.59, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.70. This value exceeds the healthy maximum of 3. It has decreased from 10.01 (Mar 24) to 5.70, marking a decrease of 4.31.
• For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to 0.11, marking an increase of 0.15.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness